The mechanism by which dihydropyridines (DHPs) modulate the electrically evoked or KCI-induced release of substance P (SP) from embryonic chick dorsal root ganglion (DRG) neurons was investigated in the present study. The release of SP, as measured by radioimmunoassay (RIA), was characterized in terms of its dependence on extracellular calcium ion, its stimulus-response relationship, its sensitivity to the calcium-channel blocker omega conus toxin (w-CgTx), and its modulation by the DHPs Bay K 8844 and nifedipine. Here it is reported that w-CgTx (1 PM) blocked the electrically evoked release of SP. In contrast, the calcium-channel agonist Bay K 8844 (5 PM) facilitated the release of SP (by 45%), whereas the calcium-channel antagonist nifedipine (5 PM) was without effect. When the release of SP was triggered by depolarization of cultures with 80 mu KCI, the actions of the DHPs became much more pronounced.
Under these conditions, Bay K 8844 facilitated (by 115%), whereas nifedipine inhibited (by 58%), peptide secretion.
Voltage-clamp analysis of DRG cell calcium currents demonstrated that these actions of o-CgTx, Bay K 8844, and nifedipine are explicable in terms of their effects on the slowly inactivating (L-type) calcium current. On the basis of these findings, it is suggested that the SP release mechanism exhibits DHP sensitivity due to the involvement of L-type calcium channels in the neurosecretory process. This model predicts that the voltage and time-dependent antagonist actions of nifedipine are sufficient to explain its failure to inhibit the electrically evoked release of SP.
Substance P (SP) is a tachykinin neuropeptide synthesized and secreted by finely myelinated and unmyelinated primary afferent neurons (Pernow, 1983a) . Subsequent to its isolation, purification, and chemical characterization by Chang and Leeman in 1970 , attention focused on the role of SP as an excitatory transmitter or modulator at spinal terminations of primary afferent nociceptors (Otsuka and Konishi, 1976; Henry, 1977 Henry, , 1982 Jesse1 and Iversen, 1977; Gamse et al., 1979; Nicoll et al., 1980; Yaksh et al., 1980) . More recently, attention has also been fo-cused on the peripheral terminations of primary afferent neurons, where released SP is implicated as a mediator of neurogenie inflammation (Pernow, 1983b (Pernow, , 1985 and as a modulator of immune system function Payan and Goetzl, 1985) . Despite the apparent importance of these diverse biological actions of SP, very little is known regarding cellular processes that regulate its release.
In an attempt to address this question, we have studied the mechanism by which depolarization induces the release of SP from embryonic chick dorsal root ganglion (DRG) neurons. It was previously reported that these primary afferent neurons synthesize and secrete SP when grown in dissociated cell culture (Mudge, 1979 (Mudge, , 1981 Mudge et al., 1979) . These earlier studies examined the mechanism by which depolarizing concentrations of KC1 induce peptide secretion. In the present paper we characterize the electrically evoked release of SP, as measured by RIA and as authenticated by high-pressure liquid chromatography (HPLC). In addition, we have begun to characterize the type of calcium channel(s) through which calcium enters to trigger secretion.
Recent electrophysiological studies have determined that 3 types of depolarization-induced calcium current may be recorded from the soma membrane of DRG neurons (Nowycky et al., 1985a) . These 3 currents presumably reflect calcium influx through 3 distinct subtypes of voltage-dependent calcium channel. Current flow through one of these, termed the L-type channel, is selectively inhibited by the dihydropyridine (DHP) calcium-channel antagonist nifedipine (Rane et al., 1987) and facilitated by the DHP calcium-channel agonist Bay K 8644 (Nowycky et al., 1985a, b) . Moreover, Pemey et al. (1986) reported that antagonist DHPs block the KCl-induced release of SP from neonate rat DRG cell cultures. In order to more fully investigate the potential role of L-type calcium channels in neurosecretory processes, we have examined whether DHPs also modulate the electrically evoked release of SP.
We now report that Bay K 8644 facilitated both the electrically evoked and KCl-induced release of SP. In contrast, nifedipine failed to inhibit release evoked by electrical-field stimulation, but reduced peptide secretion induced by 60 mM KCl. These findings are interpreted in terms of the voltage and time-dependent actions of DHPs on L-type calcium channels, as assessed by electrophysiological recordings from these same cells. A model is proposed whereby neuropeptide secretion is triggered by calcium influx through L-type calcium channels located at release sites on primary afferent nerve terminals. This model predicts that the voltage and time-dependent antagonist actions 464 Hol z et al. -Substance P and DRG Neurons A Figure I . Electrical field stimulation of DRG cell cultures. A, Design of the stimulation chamber. Bipolar platinum steel electrodes are inserted into the 60 mm tissue culture dish so that they contact the solution bathing the cells. Note that when inserted, each electrode occupies one-third of the inner circumference of the dish. B, C, Action potentials (note different time scales) recorded from the same DRG neuron in response to electrical field stimulation (square-wave DC pulses, 110 V, 3 msec duration). A single action potential is illustrated in B (arrowhead indicates stimulus artifact), whereas a train of action potentials evoked by stimulation at 25 Hz is illustrated in C. The resting potential was -58 mV. The horizontal line through the spikes indicates the zero potential determined after withdrawing the electrode from the cell. The recording solution consisted of HBS containing 2 mM Ca2+ and 1 mM Ba2+. Calibration bar: 50 mV, 10 msec (B); 50 mV, 40 msec (C). 6 C of nifedipine are sufficient to explain its failure to inhibit the electrically evoked release of SP.
Materials and Methods
Preparation of DRG cell cultures. Primary cultures of embryonic chick DRG cells were prepared as previously described (Dichter and Fischbath, 1977; Mudge et al., 1979; Dunlap and Fischbach, 1981) . DRGs from 1 1 -or 12-d-old embryos were incubated for 45 min in Ca*+-and ME*+-free Puck's solution. resusnended in Eaale's Minimal Essential Medium (MEM, supplemented 4th 7 S nerve growth factor, 5% chick embryo extract, 10% horse serum, 1 mM glutamine, 50 U/ml penicillin, and 50 &ml streptomycin), and mechanically dissociated by trituration to give a single-cell suspension. The DRG cells were gamma-irradiated (5000 rads) and plated-on 60 mm collagen-coated t&e culture dishes at a densitv of 150.000-200.000 neurons/dish. This densitv is 2-2.5 times that used in previous studies examining the electrophysiological properties of DRG cells Fischbach, 1978, 1981) . Culture medium was changed every 2-3 d beginning on day 3. The peak phase of non-neuronal cell death was observed on days 3-5.
The plating density was a critical factor in these experiments. Lower plating densities resulted in poor cell adhesion and limited neurite outgrowth. Large numbers of non-neuronal cells were observed with higher plating densities. In both cases the cellular content of SP was reduced to less than 1 &culture, whereas a cellular content of 10-l 5 @culture was observed by day 16 in those cultures that we judged to be of optimal density. Highest levels of SP were observed in cultures exhibiting dense patterns of neurites, clear cell bodies with prominent nucleoli, and few non-neuronal cells. In those cultures the cells remained firmly attached -I to the collagen substrate even with repeated exchanges of the bathing solution.
Stimulation protocol for substance P release experiments. DRG cell cultures were stimulated under sterile conditions at room temperature using bipolar platinum steel electrodes. This allowed repeated use of the same cultures for experiments on as many as 10 different days. As illustrated in Figure lA , 2 electrodes were positioned opposite each other on the outer circumference of a plastic insert that fit snugly against the inner circumference of the culture dish. Each electrode occupied onethird of the circumference of the dish, and a roof over the stimulation chamber protected against drying of the chamber contents. Stimuli (square-wave DC pulses, 3 msec duration, 110 V) were delivered at 1 Hz, and the stimulus polarity was reversed every 30 sec. Microelectrode recordings demonstrated that field stimulation generated action potentials of normal configuration in all cells tested (Fig. 1, B, C) .
Composition ofsolutions. All solutions used in the release experiments consisted of saline buffered with 25 mM HEPES, pH 7.4. The HEPESbuffered saline (HBS) contained (in mM): 132 NaCl, 2.5 KCl, 2.0 CXl,, 0.8 MgCl,, and 0.04% BSA. For solutions containing 1 mM BaZ+ or 5 mM Co*+, an appropriate volume of concentrated BaCl, or CoCl, stock solution was added directly to the HBS. Nifedipine was obtained from Sigma, Bay K 8644 from Miles Laboratories, and w-CgTx from Penninsula Laboratories. Nifedipine and Bay K 8644 were prepared as concentrated (5 mM) stock solutions in absolute ethanol. Stock solutions were diluted in HBS to give 5 PM test solutions (final concentration of ethanol, 0.10%). In all experiments examining modulation of release by dihydropyridines, control solutions (i.e., no drugs added) contained 0.10% ethanol.
Radioimmunoassay for released substance P. Field stimulation-in- duced release of SP was measured by direct radioimmunoassay (RIA) ofthe solution bathing the cells. The RIA employed an antibody specific for authentic SP (l-l 1) and its sulfoxide derivative, with less than 0.0 1% cross-reactivity to the related tachykinins physalaemin and substance K (Kream et al., 1985) . Tracer was synthesized by radioiodination of the Bolton-Hunter conjugate of SP. The specific activity of reversephase HPLC-purified tracer was approximately 2000 Ci/mmol.
Prior to electrical field stimulation, each culture was bathed in 1.7 ml of the solution to be tested. Following field stimulation, a 1.64 ml aliquot of the bathing solution was removed for RIA. To each 1.64 ml test sample was added 60 ~1 of RIA buffer, containing (in gm/liter): 44 NaCl, 10 BSA, 20 peptone, 0.2 cytochrome C, 3.7 disodium EDTA, 0.1 sodium azide, 60 HEPES, 0.01 aprotinin, 0.25 leupeptin, 25 pepstatin-A. and 0.1 phenvlmethvlsulfonvl fluoride, DH 8.0. Aliauots (0.4 ml) of this HBS/RIA buffer solution were assayed in quadruphcate.'To each aliquot was added 20 ~1 of SP antibody such that the final antibody dilution factor was 150,000-250,000-fold (33-45% of the immunoreactive tracer was bound in this range of dilutions). Next, 20 ~1 of lZ51-SP tracer was added 16 hr following addition of the antibody. The assay was equilibrated for 24 hr, and bound tracer was separated from free tracer by precipitation and centrifugation of the antibody-tracer complex in 2 ml 100% ethanol.
The sensitivity of the RIA was adjusted by varying the concentration of SP antibody. In most experiments, the IC,, value for displacement of immunoreactive tracer by nonradioactive SP was 125 pg SP/assay and the lower limit of detection was 16 pg SP/assay. Sensitivity as low as 2 pg SP/assay was obtained with more dilute antibody, but this level of detection was not required in most experiments. Standard curves were generated by assaying serial dilutions of synthetic SP standard (Sigma) that was diluted in the same HBS test solution as was used for the release experiment. Standard curves were linearized by logit-log transformation of these data. None of the drugs tested interfered with binding of the tracer to the antibody. The intra-assay coefficient of variation was less than 10%.
Authentication of substance P by HPLC. Authentication of SP extracted from DRG cell cultures was performed by reverse-phase HPLC as previously described (Kream et al., 1985) . SP was extracted in 2 ml of 6 N guanidine HCl and the extract subjected to an initial purification (step 1) by reverse-phase chromatography on Baker 10 SPE octadecyl Cl8 columns. SP was eluted in 2 ml of 50°'a CH,CN containing 0.1% CF,COOH. Aliquots (50 ~1) were lyophilized, resuspended in RIA buffer, and assayed by RIA to determine the total cellular content of SP per culture.
HPLC was performed using a 3.9 x 150 mm Waters Cl 8 Nova-Pak column. The eluate from step 1 was diluted lo-fold with distilled water, and 1 ml aliquots of this solution were serially loaded onto the column. Elution was initially achieved under isocratic conditions (8 min), with a mobile phase of 15% (wt/vol) CH,CN in 0.1% CF,COOH, followed by a linear 15-45% gradient of CH,CN in 0.1% CF,COOH (30 min). The flow rate was 1 ml/mitt, and 0.5 ml fractions were collected. Aliauots (50 ~1) of each fraction were lvonhilized. resusnended in buffer. and assayed'for SP by RIA. Recovery of SP typically-was 85-90%.
Intracellular recordings from DRG cell bodies. Intracellular microelectrode and voltage-clamp recordings of DRG cell action potentials and calcium currents were obtained as previously described (Dichter and Fischbach, 1977; Rane and Dunlap, 1986) . In both recording configurations, the extracellular solution was the same as that used in the release experiments (the divalent cation concentrations were 2 mM Ca*+ and 1 mM Ba2+), except that 0.3 I.IM tetrodotoxin was added to the solution when recording calcium currents. For whole-cell patch-clamp rcordings of calcium currents, the pipette solution contained (in mM): 150 CsCl, 5 bis(o-aminophenoxy)ethane-iV,N,N',iV-tetraacetic acid (BAPTA), 5 MgATP, and 10 HEPES (pH 7.3). All drugs were applied by pressure-ejection from a blunt-tipped micropipette.
Results

Authentication of substance P immunoreactivity
Release experiments were performed using 9-16-d-old DRG cell cultures. In preliminary experiments it was demonstrated that electrical field stimulation at 1 Hz for 30 set resulted in the appearance of detectable levels of SP immunoreactivity in the bathing solution. SP synthesized by DRG cells was judged to be authentic SP on the basis of chromatographic and im- munoreactive properties. DRG cell extracts were fractionated by reverse-phase HPLC, and the elution profile of cellular SP was monitored by RIA. As illustrated in Figure 2 , the retention time for cellular SP matched that of synthetic SP standard. In addition, a smaller peak corresponding to the sulfoxide derivative (SP-0, to which the antibody cross-reacts; Kream et al., 1985) of SP was also noted.
As expected, SP extracted, or released, from DRG cell cultures displayed a dose-dependent displacement of the binding of lz51-SP to the SP antibody. As illustrated in Figure 3 , a standard curve was generated by assaying serial dilutions of synthetic SP. When serial dilutions of cellular extract (Fig. 3 , square symbols) or released SP (circles) were assayed, the displacement curves generated displayed slopes identical to the standard curve (triangles). For these reasons, the immunoreactivity recognized by our antibody will henceforth be referred to as SP.
Characterization of the effects of divalent cations on field stimulation-induced release of substance P We characterized the effects of electrical field stimulation on the SP release process. As illustrated in Figure 4 , when cultures were bathed in HBS containing 3 mM Ca2+, stimulation (5 min at 1 Hz) increased SP levels in the bathing solution 4.5fold over baseline values (unstimulated: 68 f 16 pg/culture; stimulated: 305 f 26 pg/culture; mean f SEM; n = 3). The amount of SP released was 2.3% of the total cellular content of SP per culture (total cellular content was calculated as the sum of the amount released plus the amount remaining in the cells).
The release of SP was calcium-dependent: it was blocked by HBS containing 0.1 mM Ca*+ and 5.0 mM Co2+ (Fig. 4) . In contrast, a marked facilitation of release was observed when the HBS contained 1 mM Ba2+ and 2 mM Ca2+. In fact, Ba*+ more than doubled the amount of SP released (Fig. 4) . Note that in the presence of Ca2+, 1 mM Ba*+ was not a secretogogue: baseline levels of SP were not elevated relative to control. Intracellular Figure 3 . Parallel displacement curves generated for synthetic, cellular, and released SP. Displacement curves were linearized by logit-log transformation of the binding data. A standard curve was generated by assaying serial dilutions of synthetic SP (triangles, upper abscissa). Cellular and released SP were subjected to an initial purification on Baker 10 SPE Cl 8 columns, as described in Materials and Methods. SP was eluted in 2 ml 50% acetonitrile. Serial dilutions of the eluates were assayed for SP by RIA, and displacement curves generated for cellular (squares) and released (circles) SP. The lower abscissa indicates the volume (in ~1) of the original 2 ml eluate that was assayed by RIA. recordings demonstrated that the action of Ba2+ can be explained by its effect on the duration of DRG cell action potentials. As illustrated in the inset of Figure 4 , these action potentials exhibit a plateau phase that is reduced in duration by Co*+ and increased in duration by Ba2+ (Dichter and Fischbach, 1977) . Since the duration of the plateau phase is directly related to the amount of Ca*+ that enters with each action potential, it is likely that Ba2+ facilitates the release of SP by increasing spike duration.
Determination of the stimulus-response relationship Figure 5 illustrates the stimulus-response relationship for field stimulation-induced release of SP over a range of 60-600 stimuli delivered at a frequency of 1 Hz. In these experiments the HBS contained 1 mM Ba*+ and 2 mM Ca*+ in order to maximize the amount of SP released. Baseline and evoked levels of SP were calculated as a percentage of the total cellular content of SP per culture. Following field stimulation for 5 min, the amount of SP in the bathing solution was increased by ca. 15-fold over baseline. 2 Nine cultures from the same plating a were divided into 3 sets of 3, and each t a. set was bathed in HBS containing either 3 mM Ca2+, 1 mM Ba2+ plus 2 mM Ca2+, P or 0.1 mh4 Ca2+ plus 5 mM CoZ+, as : indicated. Baseline (shaded cofumns) ii and evoked (unshaded columns) levels z of SP were determined after 5 min exa posure to each solution. Stimuli were s delivered at 1 Hz. Each column indicates the mean + SEM for 3 cultures.
il L The average cellular content of SP was 0" 13,250 + 500 pgculture (n = 9). Inset, DRG cell action potentials recorded in 2 each solution. Calibration bars, 10 msec, 20 mV. Note that Ba2+ increased the action potential duration and facilitated SP release, whereas Co2+ decreased the action potential duration and inhibited SP release.
Dihydropyridines modulate DRG cell calcium currents and neuropeptide secretion Previous single-channel recording studies of chick DRG cells demonstrated that Bay K 8644, a DHP calcium-channel agonist, facilitates current flow through a specific subtype of calcium channel. These high-threshold, slowly inactivating calcium channels were designated as L-type by Nowycky et al. (1985a, b) . In addition, Rane et al. (1987) recently reported that current flow through these same channels is inhibited by nifedipine, a DHP calcium-channel antagonist. We examined the effects of DHPs on DRG cell action potentials and calcium currents in order to determine whether their effects on calcium influx might be correlated with their effects on the release of SP. Figure 6 illustrates the effects of DHPs on DRG cell action potentials and L-type calcium currents recorded from cells bathed in the same extracellular solution as was used in the release experiments. Intracellular microelectrode recordings demonstrated that Bay K 8644 (5 PM) increased the duration of the (Fig. 6, A, B) . In contrast, in 20 of 20 cells tested, nifedipine (5 PM) failed to alter the duration of the action potential (Fig. 6c) , but decreased the amplitude of the L-type calcium current in 9 of 13 cells (average decrease of 38 f 5%; mean f SEM) when the current was evoked from a relatively depolarized holding potential (-30 mV) that had been maintained for 5 set or more, as illustrated in Figure 6E . In contrast, when the L-type current was evoked from a holding potential that approximated the normal resting potential of DRG neurons (-70 mV), nifedipine was relatively ineffective (Fig. 60) . These findings are consistent with the previously reported voltage and time-dependent actions of DHPs on L-type currents (Sanguinetti and Kass, 1984; Sanguinetti et al., 1986; Rane et al., 1987) . Next, we examined the effects of Bay K 8644 and nifedipine on SP release in order to determine whether the release process is triggered by calcium influx through L-type calcium channels. Neuropeptide secretion was induced by either field stimulation or depolarization with HBS containing 60 mM KCl. The amount of SP released was calculated as a percentage of the total cellular content of SP per culture prior to stimulation. As summarized in Table 1 A, under conditions in which the HBS contained 2 mM CaCl, and 1 mM BaCl,, treatment with Bay K 8644 (5 PM) increased field stimulation-induced release of SP by 45% relative to control. In contrast, nifedipine (5 PM, a concentration that is saturating for inhibition of L-type calcium currents in DRG neurons; Rane et al., 1987) did not significantly affect the release of SP, although an inhibitory trend was noted (Table 1A) .
The failure of nifedipine to inhibit the electrically evoked release of SP can be explained by the fact that this DHP inhibits calcium-channel function in a voltage and time-dependent manner (cf. Fig. 6, D, E) . That is, in previous studies of L-type calcium currents, the inhibitory action of nifedipine was accentuated by prior depolarization of the resting membrane potential (Sanguinetti and Kass, 1984; Rane et al., 1987) . We tested for such a voltage and time-dependent action of nifedipine by examining its effects on the release of SP induced by prolonged depolarization of cultures with KCl.
When the release of SP was induced by 60 mM KCl, the actions of the DHPs became much more pronounced. In these exper- Figure 5 . Stimulus-response relationship for electrically evoked release of SP. Fifteen DRG cell cultures from the same plating were divided into 5 sets of 3, and each set was stimulated for either 60, 90, 150, 300, or 600 set at 1 Hz. The HBS contained 1 mM Ba2+ and 2 mM Caz+. Each point indicates the mean k SEM value for 3 cultures. The average cellular content of SP was 12,800 + 600 pg/culture (n = 15). 6dO iments, baseline values of SP were determined by exposing cultures for 5 min to HBS containing (in mM): 132 NaCl, 2.5 KCl, 2 CaCl,, and 1 BaCl,. For DHP-treated cultures, baseline values were determined in the presence of nifedipine or Bay K 8644. Next, cultures were depolarized for 5 min by HBS containing reduced NaCl(74 mM) and elevated KC1 (60 mM). Intracellular recordings demonstrated that this concentration of KC1 depolarized the resting membrane potential to -26 f 1 mV (n = 5 neurons), thereby inducing the calcium-dependent release of SP. As summarized in Table lB, Bay K 8644 (5 PM) more than doubled the amount of SP released relative to control, whereas Conus toxin blocks DRG cell calcium currents and substance P release It was recently reported that the molluscan neurotoxin w-CgTx, isolated from Conusgeographus by Olivera et al. (1984) , inhibits calcium influx associated with DRG action potentials (Kerr and Yoshikami, 1984) and blocks L-and N-type calcium currents in DRG cell bodies (McCleskey et al., 1986; Feldman et al., 1987) . To further substantiate a role for L-type calcium channels in neuropeptide secretion, we examined the effects of w-CgTx on the electrically evoked release of SP. As illustrated in Figure   7 , A-C, w-CgTx (1 PM) decreased the duration of DRG cell action potentials, irreversibly blocked the L-type calcium current, and inhibited the electrically evoked release of SP. Discussion Calcium-dependent release of substance P The findings of the present study confirm previous reports that embryonic chick DRG neurons synthesize and secrete authentic SP when grown in primary dissociated cell culture (Mudge, 1979, 198 1; Mudge et al., 1979) . These earlier studies examined the mechanism by which depolarizing concentrations of KC1 induce neuropeptide secretion. We have extended these original observations by characterizing the electrically evoked release of SP in terms of its calcium-dependence, stimulus-response relationship, and its modulation by w-CgTx and DHPs.
Three observations indicate that the electrically evoked release of SP does not result from nonspecific electropermeabilization of DRG cell membranes. First, intracellular recordings demonstrated that DRG neurons fire action potentials of normal configuration in response to electrical field stimulation. Secondly, the electrically evoked release of SP was fully repeatable, and, following stimulation, baseline levels of released SP returned to prestimulus levels, indicating that field stimulation does not damage the cells. Third, release was blocked by solutions containing either 5 mM Co*+ or 1 PM w-CgTx. This is as expected for a process of calcium-dependent exocytosis, since little or no depolarization-induced calcium current is recorded from the soma membrane of DRG neurons bathed in such solutions (Dunlap and Fischbach, 198 1; Fig. 7) . Therefore, the The Journal of Neuroscience, February 1988, 8(2) 469 electrically evoked release of SP appears to be triggered by calcium influx through voltage-dependent calcium channels.
A role for L-type calcium channels in neuropeptide secretion We have also demonstrated that the release of SP is facilitated by the DHP calcium-channel agonist Bay K 8644, and is inhibited by the DHP calcium-channel antagonist nifedipine. Significantly, it is now known that Bay K 8644 and nifedipine modulate slowly inactivating L-type calcium currents recorded from the soma membrane of DRG neurons (Nowycky et al., 1985a, b; Rane et al., 1987) . In contrast, fast-inactivating (Nand T-type) calcium currents do not appear to be affected by either drug (Nowycky et al., 1985a , b, Rane et al., 1987 . On the basis of these findings, we propose that DHPs modulate the release of SP by regulating calcium influx through L-type calcium channels located at release sites on primary afferent neurons. It remains to be determined exactly where these release sites are located. For example, it might be argued that the release of SP is triggered by calcium influx through L-type calcium channels located in sensory nerve terminals. Alternatively, an action of Bay K 8644 or nifedipine on L-type calcium channels located in the somatic membrane of DRG neurons might explain the DHP sensitivity of the SP release mechanism. It is therefore important to recognize the limitations of release experiments conducted in dissociated cell culture where the sites of neuropeptide secretion remain undefined.
Voltage-and time-dependent actions of nifedipine In the present study it was found that nifedipine inhibited the release of SP only under conditions of KCl-induced depolarization. No significant inhibitory action of the antagonist was observed when release was induced by electrical field stimulation. Moreover, nifedipine failed to inhibit calcium influx associated with DRG cell action potentials. These findings are explicable in terms of the voltage and time-dependent actions of DHPs on L-type calcium currents. Specifically, it was previously reported, and confirmed in the present study, that nifedipine inhibits L-type calcium currents most effectively when the membrane potential is held at depolarized levels (5 -30 mV) for 5 set or more (Sanguinetti and Kass, 1984; Rane et al., 1987) . Clearly, such conditions are not achieved during electrical field stimulation, where SP release is triggered by action potentials of relatively short duration (10-50 msec) evoked from resting membrane potentials of -60 to -70 mV.
In contrast, when cultures were depolarized by 60 mM KCl, 5 MM nifedipine inhibited the release of SP by 58%. Similar inhibitory actions of DHP calcium-channel antagonists were reported in previous studies examining KCl-induced calcium uptake into, or transmitter release from, rat DRG cells (Pemey et al., 1986) , cerebellar and retinal neurons (Takahashi and Ogura, 1983; Carboni et al., 1985) , neuronal cell lines (Freedman et al., 1984) PC 12 cells (Toll, 1982) pituitary cells (Enyeart et al., 1985; Chang et al., 1986) and rat brain synaptosomes (Turner and Goldin, 1985) .
Modulation of substance P release by Bay K 8644 The action of Bay K 8644 differed from that of nifedipine in that this calcium-channel agonist facilitated both the KCl-induced and electrically evoked release of SP. Furthermore, Bay K 8644 increased calcium influx associated with DRG cell action potentials. These findings are also explicable in terms of the voltage and time-dependent actions of DHPs. Modulation of L-type calcium currents by Bay K 8644 does not require prior depolarization of the membrane potential. In fact, the agonist action of Bay K 8644 is most easily observed when L-type calcium currents are evoked from membrane potentials (-70 mV) close to the normal resting potential of DRG cells (see Fig.  6 , A, B; see also Nowycky et al., 1985a, b; Sanguinetti et al., 1986) . Such conditions are achieved during electrical field stimulation of DRG cells.
How these findings relate to previous studies examining the DHP sensitivity of neurosecretion The findings reported herein are noteworthy in that they emphasize the limited usefulness of DHPs as pharmacological probes for L-type calcium channels. In particular, we have demonstrated that nifedipine inhibits, but does not completely block, the L-type calcium current, and that this antagonist action is both voltage and time-dependent. An understanding of such limitations is essential in order to properly evaluate previous studies reporting the failure of DHP calcium-channel antagonists to inhibit KCl-induced transmitter release from synaptosomal and brain slice preparations (reviewed by Miller, 1985) . This failure to block secretion has been taken to indicate that in the central nervous system, calcium influx through L-type calcium channels does not normally trigger transmitter release (reviewed by Miller, 1987) .
The findings of the present study suggest an alternative interpretation. We propose that the relatively slow antagonist action of DHPs (as reported here, and previously by Sanguinetti and Kass, 1984; Rane et al., 1987) severely limits their ability to inhibit transmitter release triggered by calcium influx during the initial phase (i.e., first 5 set) of KCl-induced depolarization. This model predicts that antagonist DHPs will be effective only when the time course of transmitter release overlaps with the onset of L-type calcium-channel blockade, as is apparently the case during KCl-induced release of SP from DRG cell cultures.
In contast, in those systems in which calcium influx and transmitter release are very transient in nature, no effect of antagonist DHPs is to be expected. For example, it was previously reported that DHPs fail to inhibit KCl-induced calcium uptake into rat brain synaptosomal preparations (Nachshen and Blaustein, 1979; Daniel1 et al., 1983; Reynolds et al., 1986; Suszkiw et al., 1986) . However, it is also well documented that the rapid phase of KCl-induced calcium uptake into, and transmitter release from, synaptosomes is primarily limited to the first l-2 set of sustained depolarization (Drapeau and Blaustein, 1983; Floor, 1983; Turner and Goldin, 1985; Suszkiw et al., 1986) . Our findings indicate that this time course of calcium influx may be too transient to allow effective blockade of the synaptosomal release mechanism by DHPs. In fact, such transient kinetics may result from rapid calcium-dependent inactivation of L-type calcium channels as intracellular levels of free calcium rise (Eckert and Chad, 1984) . For these reasons, we wish to emphasize that in future studies examining the actions of DHPs, it will be necessary to obtain detailed information regarding the time course of calcium influx and transmitter release.
What is the role of N-and T-type calcium channels? An important question that remains to be answered is whether calcium influx through N-or T-type calcium channels also triggers the release of SP from DRG neurons. On the basis of previous studies examining N-and T-type calcium currents in the chick DRG soma membrane (Nowvckv et al.. 1985a) . we from rat striatal synaptosomes: Correlation with calcium entry. J. For example, it might be argued that the electrically evoked that DHP-insensitive (N-or T-type) calcium channels also play (and therefore physiologically relevant) release of SP results from calcium influx through N-or T-type channels, whereas L-type channels mediate secretion induced by KC1 (see Miller, 1987) . Armstrong, and M. B. Jackson, eds., Plenum (in press). Eckert, R., and J. E. Chad (1984) Inactivation of Ca channels. Prog. ou the release of SP most likelv results from Ca2+ influx through r observation that w-CgTx blocked the electrically evoked release of SP appears to rule out such a role for T-type channels, since current flow through this channel subtype was reported to be insensitive to the toxin (McCleskey et al., 1987) . Therefore, either N-or L-type channels, or possibly both. It must be emphasized, however, that the w-CgTx effects reported herein do not resolve the question of which channel subtype is most important to the secretory process. Micromolar concentrations of w-CgTx were previously reported to block both N-and L-type calcium currents (McCleskey et al., 1987) . Therefore, this question will only be answered when more specific pharmacological probes for N-and L-type calcium channels are discovered. Transmitter modulation of DHP-sensitive calcium channels It was previously reported that norepinephrine (NE) and GABA inhibit DHP-sensitive, L-type calcium currents recorded from chick DRG cell bodies (Dunlap and Fischbach, 1981; Holz et al., 1986a; Rane et al., 1987) . Since NE and GABA also inhibit the calcium-dependent release of SP from chick DRG cell cultures (Dunlap et al., 1986; Holz et al., 1986b) , the transmitters may presynaptically inhibit neuropeptide secretion by regulating calcium influx through L-type calcium channels located at release sites on sensory nerve terminals (Dunlap et al., 1987) . The findings of the present study support this concept. We have demonstrated that the depolarization-induced release of SP exhibits DHP sensitivity, as would be expected if calcium influx through L-type calcium channels triggers neuropeptide secretion. It may be concluded that in primary afferent neurons, the regulation of L-type calcium channels by neurotransmitters is likely to play an important role in processes governing the inhibition or facilitation of neurosecretion.
